Histoplasmosis beyond HIV: Clinical characteristics and outcomes in non-HIV population

A C Tello-Mercado,B Martínez-Guerra,C M Román-Montes,L Seoane-Hernandez,A Rangel-Cordero,R A Martínez-Gamboa,J Sifuentes-Osornio,A Ponce-de-León,M F González Lara,M D Niembro-Ortega
DOI: https://doi.org/10.1093/ofid/ofae079
2024-02-15
Open Forum Infectious Diseases
Abstract:Abstract Histoplasmosis is an endemic and invasive mycosis caused by Histoplasma capsulatum. We conducted a retrospective study comparing non-HIV immunosuppressed patients with a historical cohort of HIV and histoplasmosis. We included 199 patients with proven or probable histoplasmosis, of which 25.1% were non-HIV. Diabetes mellitus, chronic kidney disease, hematologic neoplasms, rheumatologic diseases and transplants were more frequent among non-HIV patients (p<0.01). Death after diagnosis occurred in 44% patients. 44% of immunocompromised non-HIV patients died within the first 6-week period following their diagnosis. A high suspicion index for histoplasmosis should be kept in immunosuppressed patients.
immunology,infectious diseases,microbiology
What problem does this paper attempt to address?